Swiss drugmaker Novartis allegedly used kickbacks to boost sales of Exjade and Myfortic, and is now facing a $3.35 billion lawsuit in damages and fines.
Swiss drugmaker Novartis allegedly used kickbacks to boost sales of Exjade and Myfortic, and is now facing a $3.35 billion lawsuit in damages and fines.